CCL — CCL Products (India) Balance Sheet
0.000.00%
- IN₹113.16bn
- IN₹130.30bn
- IN₹31.06bn
- 61
- 15
- 99
- 64
Annual balance sheet for CCL Products (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,172 | 561 | 826 | 1,691 | 1,009 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,349 | 3,572 | 5,199 | 7,396 | 6,903 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7,911 | 9,913 | 12,472 | 17,411 | 20,876 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9,473 | 10,422 | 13,110 | 17,526 | 20,721 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 17,882 | 20,699 | 25,969 | 35,359 | 42,410 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,687 | 6,301 | 8,350 | 12,772 | 16,367 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 7,009 | 8,192 | 10,996 | 18,621 | 22,737 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 10,873 | 12,507 | 14,973 | 16,738 | 19,672 |
Total Liabilities & Shareholders' Equity | 17,882 | 20,699 | 25,969 | 35,359 | 42,410 |
Total Common Shares Outstanding |